Bank of America’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,800
| Closed | -$4.79K | – | 7496 |
|
|
2024
Q1 | $4.79K | Sell |
1,800
-3,973
| -69% | -$10.6K | ﹤0.01% | 6114 |
|
|
2023
Q4 | $13.7K | Sell |
5,773
-2,275
| -28% | -$5.39K | ﹤0.01% | 5913 |
|
|
2023
Q3 | $11.3K | Sell |
8,048
-5,579
| -41% | -$7.81K | ﹤0.01% | 5916 |
|
|
2023
Q2 | $41.3K | Sell |
13,627
-10,919
| -44% | -$33.1K | ﹤0.01% | 5658 |
|
|
2023
Q1 | $153K | Sell |
24,546
-5,306
| -18% | -$33.2K | ﹤0.01% | 5268 |
|
|
2022
Q4 | $182K | Sell |
29,852
-14,791
| -33% | -$90.2K | ﹤0.01% | 5235 |
|
|
2022
Q3 | $534K | Sell |
44,643
-13,306
| -23% | -$159K | ﹤0.01% | 4609 |
|
|
2022
Q2 | $731K | Buy |
57,949
+40,773
| +237% | +$514K | ﹤0.01% | 4486 |
|
|
2022
Q1 | $193K | Sell |
17,176
-9,550
| -36% | -$107K | ﹤0.01% | 5733 |
|
|
2021
Q4 | $473K | Buy |
26,726
+7,354
| +38% | +$130K | ﹤0.01% | 5148 |
|
|
2021
Q3 | $446K | Buy |
19,372
+14,109
| +268% | +$325K | ﹤0.01% | 4945 |
|
|
2021
Q2 | $123K | Sell |
5,263
-21,919
| -81% | -$512K | ﹤0.01% | 5623 |
|
|
2021
Q1 | $847K | Buy |
+27,182
| New | +$847K | ﹤0.01% | 4404 |
|